QUEBEC CITY, Sept. 27 /PRNewswire-FirstCall/ -- AEterna Zentaris Inc. (TSX: AEZ; Nasdaq: AEZS), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that it will host a conference call and webcast on Tuesday, October 2, 2007 at 11:00 a.m. Eastern time regarding the outcome of management's strategic review of the Company's pipeline and business operations. Participants may access the live webcast via the Company's website at http://www.aeternazentaris.com/ in the "Investors" section, or by telephone using the following numbers: 416-644-3414, 514-807-8791 or 800-733-7571. A replay of the webcast will also be available on the Company's website for a period of 30 days. About AEterna Zentaris Inc. AEterna Zentaris Inc. is global biopharmaceutical company focused on endocrine therapy and oncology with proven expertise in drug discovery, development and commercialization. News releases and additional information are available at http://www.aeternazentaris.com/. DATASOURCE: AETERNA ZENTARIS INC. CONTACT: Jenene Thomas, Senior Director, Investor Relations & Corporate Communications, (908) 938-1475, ; Paul Burroughs, Media Relations, (418) 652-8525 ext. 406,

Copyright